查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2068696

醫療機器人市場預測至2034年—按產品類型、組件、技術、控制方法、應用、最終用戶和地區分類的全球分析

Medical Robotics Market Forecasts to 2034 - Global Analysis By Product Type, Component, Technology, Control Mechanism, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫療機器人市場規模將達到 168 億美元，到 2034 年將達到 552 億美元，預測期內複合年成長率為 16.1%。

醫療機器人涵蓋多種機器人系統，旨在輔助或自動化外科手術、復健、診斷和醫院後勤等領域的臨床任務。手術機器人透過防手震和改善視野來提高外科醫生的手術精確度，而復健機器人則幫助神經系統和整形外科疾病患者恢復運動功能。醫院和藥房的機器人可以自動完成藥品分發、消毒和物資配送等任務，從而減輕人工勞動負擔並降低人為錯誤的發生率。

微創手術在全球的普及

患者和臨床對微創手術的需求日益成長，推動了機器人手術在各個專科領域的持續發展。機器人平台即使在有限的解剖空間內也能提供卓越的操控性，從而能夠透過更小的切口完成複雜的手術。因此，術後疼痛得以減輕，住院時間得以縮短，患者復健速度也得以加快。醫療系統管理者意識到提供機器人手術計畫所帶來的聲譽和報銷優勢，這促使他們對外科機器人技術進行投資。隨著手術數量的增加和營運經驗的積累，單次手術成本不斷降低，進一步提升了機器人手術平台的經濟效益，並使其應用範圍從三級醫療機構擴展到已開發市場和新興市場的區域醫院。

外科手術系統需要大量的資本投入和陡峭的學習曲線。

對於低收入國家的小規模醫院和醫療系統而言，先進手術機器人系統的初始投資成本仍然是一大障礙。除了硬體投資外，醫療機構還必須為耗材手術器械、維護合約和大規模手術培訓計畫預留預算，這顯著增加了總擁有成本。機器人手術的學習曲線意味著外科醫生需要進行大量的手術才能達到最佳效率，這導致在完全具備操作運作之前的這段時間內存在機會成本。新機器人醫療設備嚴格的法規核准流程耗時較長，延長了新參與企業獲利的時間，並限制了市場創新的步伐。

新一代自主和人工智慧引導機器人平台的出現。

將機器學習、電腦視覺和自主控制系統整合到醫療機器人中，正在催生新一代平台，這些平台能夠半自動執行手術、提供即時術中引導和自適應手術規劃。人工智慧引導的機器人可以分析術前影像，產生精確的手術圖，並即時提醒外科醫生注意關鍵的解剖結構。在復健領域，人工智慧驅動的外骨骼可以根據持續的動態回饋來調整運動強度。這些功能顯著擴展了機器人平台的價值提案，使其超越了傳統的人工輔助，開闢了新的臨床應用領域，並為下一代產品的上市創造了強大的差異化優勢。

設備故障和嚴格的上市後監管要求

由於技術缺陷導致機器人手術併發症的報告屢見不鮮，促使監管機構加強對醫療機器人上市後監測義務的監管。監管機構要求醫療器材製造商進行更全面的不利事件報告、真實世界證據收集和性能追蹤項目，這增加了製造商的持續合規成本。即使作為預防措施，產品召回也會對醫療設備商的聲譽和財務造成重大影響。現代機器人系統複雜的機械和軟體架構會產生多個潛在故障點，因此製造商必須維護完善的品管系統和快速的現場服務能力，才能滿足安全要求。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對醫療機器人產業造成了重大衝擊，部分手術被迫中斷，導致2020年大部分時間手術量和機器人運轉率急劇下降。然而，這場危機也凸顯了機器人系統在最大限度降低醫護人員在某些手術中接觸感染患者風險的效用。疫情過後，隨著醫院努力清理候診名單，機器人手術的數量開始回升。這項經驗也提高了人們對用於消毒和物流的自主醫院機器人的興趣。自疫情爆發以來，該領域發展尤為強勁，並持續吸引投資。

在預測期內，外科手術機器人領域預計將佔據最大的市場規模。

預計在預測期內，手術機器人領域將佔據最大的市場佔有率。這是因為機器人手術平台的高昂單價以及每次手術產生的大量耗材銷售額將推動市場總收入的大部分成長。腹腔鏡和泌尿系統機器人系統在已開發國家的醫院中已實現了顯著的滲透率，其中整形外科。

預計在預測期內，雲端運算機器人領域將呈現最高的複合年成長率。

在預測期內，雲端機器人領域預計將呈現最高的成長率。雲端連接的機器人平台將運行資料傳輸到集中式分析引擎，從而實現遠端效能監控、預測性維護以及透過空中下載更新進行持續的軟體最佳化。這種架構允許在部件發生故障之前進行主動維護，從而顯著減少停機時間。雲端連接還有助於實現遠端手術應用，使專家外科醫生能夠遠端指導手術。隨著醫院IT基礎設施的成熟和醫療設備網路安全態勢的增強，預計所有機器人平台類別都將加速採用雲端機器人技術。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要得益於主要供應商率先將機器人手術系統推向市場，以及這些系統在醫療機構的廣泛應用。美國在全球機器人手術領域佔據主導地位，這得益於其充足的醫院資本支出預算、完善的機器人輔助手術私人保險報銷機制，以及大學和社區醫院積極採用新技術的文化。加之北美完善的醫療設備監管體系和龐大的慢性病患者群體，預計北美將在整個預測期內繼續引領市場。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、日本、印度和韓國醫療基礎設施投資的快速成長。中國政府已將醫療機器人列為國家戰略產業，並透過研發補貼計畫和醫院採購獎勵支持國內製造商。在日本，人口老化推動了對復健機器人和精準手術的需求成長。在該地區，越來越多富裕的都市區患者願意支付微創手術費用，加上醫療系統容量的不斷擴大，共同構成了強勁的結構性成長動力。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性評估）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫療機器人市場：依產品類型分類

  • 手術機器人
    • 腹腔鏡手術機器人
    • 整形外科機器人
    • 神經外科機器人
    • 心臟手術機器人
    • 婦科機器人
    • 泌尿系統機器人
    • 通用外科手術機器人
  • 復健機器人
  • 醫院和藥局的機器人
    • 自動分發機器人
    • 消毒和衛生管理機器人
    • 配送和運輸機器人
    • 遠端臨場機器人
  • 診斷機器人
  • 用於放射治療的機器人

第6章 全球醫療機器人市場：依組件分類

  • 機器人系統
  • 設備和配件
  • 軟體
  • 服務

第7章 全球醫療機器人市場：依技術分類

  • 人工智慧（AI）
  • 機器學習
  • 電腦視覺
  • 觸覺技術
  • 醫療物聯網（IoMT）
  • 雲機器人

第8章 全球醫療機器人市場：以控制方式分類

  • 直接遙控機械手臂系統
  • 電腦控制系統
  • 共用控制系統

第9章 全球醫療機器人市場：依應用領域分類

  • 外科手術
  • 復健治療
  • 診斷
  • 藥房自動化
  • 醫院物流
  • 遠端照護
  • 老年護理
  • 放射線治療

第10章：全球醫療機器人市場：以最終用戶分類

  • 醫院
  • 門診手術中心
  • 專科診所
  • 復健中心
  • 研究機構
  • 藥局

第11章 全球醫療機器人市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Intuitive Surgical
  • Stryker
  • Medtronic
  • Zimmer Biomet
  • Johnson & Johnson
  • Smith & Nephew
  • CMR Surgical
  • Asensus Surgical
  • Accuray
  • Omnicell
  • Siemens Healthineers
  • GE HealthCare
  • Globus Medical
  • Renishaw plc
  • Brainlab AG
Product Code: SMRC37049

According to Stratistics MRC, the Global Medical Robotics Market is accounted for $16.8 billion in 2026 and is expected to reach $55.2 billion by 2034, growing at a CAGR of 16.1% during the forecast period. Medical Robotics encompasses a diverse range of robotic systems designed to augment or automate clinical tasks across surgical, rehabilitative, diagnostic, and hospital logistics domains. Surgical robots extend surgeon precision through tremor filtration and enhanced visualization, while rehabilitation robots support motor function recovery for neurological and orthopedic patients. Hospital and pharmacy robots automate medication dispensing, disinfection, and supply delivery, reducing manual workload and human error rates.

Market Dynamics:

Driver:

Growing adoption of minimally invasive surgical procedures globally

Patient and clinical preference for minimally invasive surgery continues to expand robotic surgery adoption across diverse specialties. Robotic platforms deliver superior dexterity in confined anatomical spaces, enabling complex procedures through smaller incisions that result in reduced postoperative pain, shorter hospital stays, and faster patient recovery. Health system administrators recognize the reputational and reimbursement advantages of offering robotic surgery programs, stimulating capital investment in surgical robotics. As procedure volumes grow and per-procedure costs decline through operational experience, the economic case for robotic surgery platforms strengthens, broadening adoption from tertiary centers to community hospitals in developed and emerging markets alike.

Restraint:

High capital investment and steep learning curves for surgical systems

The upfront acquisition cost of sophisticated surgical robotic systems remains a significant barrier for smaller hospitals and healthcare systems in lower-income countries. Beyond hardware investment, institutions must budget for consumable instruments, maintenance contracts, and extensive surgeon training programs, substantially increasing the total cost of ownership. The learning curve associated with robotic surgery proficiency requires significant case volumes before surgeons achieve optimal efficiency, creating opportunity costs during the ramp-up period. Regulatory approval processes for novel robotic devices are rigorous and time-consuming, extending time-to-revenue for new entrants and constraining the pace of market innovation.

Opportunity:

Emergence of next-generation autonomous and AI-guided robotic platforms

The integration of machine learning, computer vision, and autonomous control systems into medical robotics is ushering in a new generation of platforms capable of semi-autonomous procedure execution, real-time intraoperative guidance, and adaptive surgical planning. AI-guided robots can analyze pre-operative imaging to generate precise surgical maps and alert surgeons to critical anatomical structures in real time. In rehabilitation, AI-powered exoskeletons adapt exercise intensity based on continuous biomechanical feedback. These capabilities substantially expand the value proposition of robotic platforms beyond traditional manual task assistance, opening new clinical application areas and creating compelling differentiation for next-generation product launches.

Threat:

Device malfunctions and stringent post-market surveillance requirements

High-profile reports of robotic surgery complications attributable to technical malfunctions have intensified regulatory scrutiny of medical robotics post-market surveillance obligations. Regulatory agencies are mandating more comprehensive adverse event reporting, real-world evidence generation, and device performance tracking programs, increasing ongoing compliance costs for manufacturers. Product recalls, even when precautionary, generate significant reputational and financial consequences. The complex mechanical and software architectures of modern robotic systems create multiple potential failure points, requiring manufacturers to maintain extensive quality management systems and rapid field service capabilities to meet safety expectations.

Covid-19 Impact:

The COVID-19 pandemic created significant disruption for medical robotics through the suspension of elective surgeries, which sharply reduced procedure volumes and robot utilization for the majority of 2020. However, the crisis also validated the utility of robotic systems in minimizing clinical staff exposure to infectious patients during certain procedures. Post-pandemic surgical backlogs are driving elevated robotic procedure volumes as hospitals work to clear waiting lists. The experience also accelerated interest in autonomous hospital robots for disinfection and logistics, a segment that saw particularly strong growth following the pandemic and maintains elevated investment activity.

The Surgical Robots segment is expected to be the largest during the forecast period

The Surgical Robots segment is expected to account for the largest market share during the forecast period, driven by the majority of total market revenue driven by the high unit values of robotic surgical platforms and the substantial consumable instrument revenue generated per procedure. Laparoscopic and urological robotic systems have achieved significant penetration in developed market hospitals, with orthopedic robots representing the fastest-growing sub-category within this segment. The concentration of major robotics vendors' commercial efforts in surgical applications, combined with growing surgeon preference for robotic-assisted techniques across soft tissue and hard tissue specialties, solidifies surgical robots' dominant market position.

The Cloud Robotics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Cloud Robotics segment is predicted to witness the highest growth rate. Cloud-connected robotic platforms transmit operational data to centralized analytics engines, enabling remote performance monitoring, predictive maintenance, and continuous software optimization through over-the-air updates. This architecture dramatically reduces downtime by enabling proactive servicing before component failure. Cloud connectivity also facilitates telesurgery applications, where expert surgeons can guide procedures at remote sites. As hospital IT infrastructure matures and cybersecurity frameworks for medical devices strengthen, cloud robotics adoption is expected to accelerate across all robotic platform categories.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by the early market entry and widespread institutional adoption of robotic surgery systems from leading vendors. The United States accounts for the majority of global robotic surgical procedures, supported by favorable hospital capital budgets, robust private insurance reimbursement for robotic-assisted procedures, and a culture of technology adoption in academic and community hospital settings. A well-established regulatory pathway for medical devices, combined with a large population requiring chronic disease-related surgical intervention, ensures North America's continued market leadership through the forecast horizon.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by rapidly expanding healthcare infrastructure investment across China, Japan, India, and South Korea. China's government has identified medical robotics as a strategic national industry, supporting domestic manufacturers through subsidized R&D programs and hospital procurement incentives. Japan's aging population generates increasing demand for rehabilitation robots and surgical precision. The region's growing population of affluent urban patients willing to pay for minimally invasive surgical procedures, combined with healthcare system capacity expansion, creates strong structural growth dynamics.

Key players in the market

Some of the key players in Medical Robotics Market include Intuitive Surgical, Stryker, Medtronic, Zimmer Biomet, Johnson & Johnson, Smith & Nephew, CMR Surgical, Asensus Surgical, Accuray, Omnicell, Siemens Healthineers, GE HealthCare, Globus Medical, Renishaw plc, Brainlab AG.

Key Developments:

In April 2026, Zimmer Biomet Zimmer Biomet reported strong adoption metrics for its ROSA robotic surgery platform in total knee and total hip arthroplasty procedures, announcing expanded training center partnerships to accelerate surgeon certification programs and broaden institutional access to robotic orthopedic surgery capabilities across North American hospital networks.

In February 2026, Intuitive Surgical Intuitive Surgical announced the commercial launch of its da Vinci 5 robotic surgical system featuring enhanced force feedback capabilities and an expanded instrument portfolio, marking a significant product generational upgrade designed to improve surgical precision across soft tissue and reconstructive procedures in complex anatomical environments.

Product Types Covered:

  • Surgical Robots
  • Rehabilitation Robots
  • Hospital & Pharmacy Robots
  • Diagnostic Robots
  • Radiotherapy Robots

Components Covered:

  • Robotic Systems
  • Instruments & Accessories
  • Software
  • Services

Technologies Covered:

  • Artificial Intelligence (AI)
  • Machine Learning
  • Computer Vision
  • Haptic Technology
  • IoMT
  • Cloud Robotics

Control Mechanisms Covered:

  • Direct Telemanipulator Systems
  • Computer-Controlled Systems
  • Shared-Control Systems

Applications Covered:

  • Surgery
  • Rehabilitation Therapy
  • Diagnostics
  • Pharmacy Automation
  • Hospital Logistics
  • Telemedicine
  • Elderly Care
  • Radiation Therapy

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Rehabilitation Centers
  • Research Institutes
  • Pharmacies

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
      • Saudi Arabia
      • United Arab Emirates
      • Qatar
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Egypt
      • Morocco
      • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Medical Robotics Market, By Product Type

  • 5.1 Surgical Robots
    • 5.1.1 Laparoscopic Robots
    • 5.1.2 Orthopedic Robots
    • 5.1.3 Neurosurgical Robots
    • 5.1.4 Cardiology Robots
    • 5.1.5 Gynecology Robots
    • 5.1.6 Urology Robots
    • 5.1.7 General Surgery Robots
  • 5.2 Rehabilitation Robots
  • 5.3 Hospital & Pharmacy Robots
    • 5.3.1 Automated Dispensing Robots
    • 5.3.2 Disinfection & Sanitization Robots
    • 5.3.3 Delivery & Transportation Robots
    • 5.3.4 Telepresence Robots
  • 5.4 Diagnostic Robots
  • 5.5 Radiotherapy Robots

6 Global Medical Robotics Market, By Component

  • 6.1 Robotic Systems
  • 6.2 Instruments & Accessories
  • 6.3 Software
  • 6.4 Services

7 Global Medical Robotics Market, By Technology

  • 7.1 Artificial Intelligence (AI)
  • 7.2 Machine Learning
  • 7.3 Computer Vision
  • 7.4 Haptic Technology
  • 7.5 Internet of Medical Things (IoMT)
  • 7.6 Cloud Robotics

8 Global Medical Robotics Market, By Control Mechanism

  • 8.1 Direct Telemanipulator Systems
  • 8.2 Computer-Controlled Systems
  • 8.3 Shared-Control Systems

9 Global Medical Robotics Market, By Application

  • 9.1 Surgery
  • 9.2 Rehabilitation Therapy
  • 9.3 Diagnostics
  • 9.4 Pharmacy Automation
  • 9.5 Hospital Logistics
  • 9.6 Telemedicine
  • 9.7 Elderly Care
  • 9.8 Radiation Therapy

10 Global Medical Robotics Market, By End User

  • 10.1 Hospitals
  • 10.2 Ambulatory Surgical Centers
  • 10.3 Specialty Clinics
  • 10.4 Rehabilitation Centers
  • 10.5 Research Institutes
  • 10.6 Pharmacies

11 Global Medical Robotics Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Intuitive Surgical
  • 14.2 Stryker
  • 14.3 Medtronic
  • 14.4 Zimmer Biomet
  • 14.5 Johnson & Johnson
  • 14.6 Smith & Nephew
  • 14.7 CMR Surgical
  • 14.8 Asensus Surgical
  • 14.9 Accuray
  • 14.10 Omnicell
  • 14.11 Siemens Healthineers
  • 14.12 GE HealthCare
  • 14.13 Globus Medical
  • 14.14 Renishaw plc
  • 14.15 Brainlab AG

List of Tables

  • Table 1 Global Medical Robotics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Medical Robotics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Medical Robotics Market Outlook, By Surgical Robots (2023-2034) ($MN)
  • Table 4 Global Medical Robotics Market Outlook, By Laparoscopic Robots (2023-2034) ($MN)
  • Table 5 Global Medical Robotics Market Outlook, By Orthopedic Robots (2023-2034) ($MN)
  • Table 6 Global Medical Robotics Market Outlook, By Neurosurgical Robots (2023-2034) ($MN)
  • Table 7 Global Medical Robotics Market Outlook, By Cardiology Robots (2023-2034) ($MN)
  • Table 8 Global Medical Robotics Market Outlook, By Gynecology Robots (2023-2034) ($MN)
  • Table 9 Global Medical Robotics Market Outlook, By Urology Robots (2023-2034) ($MN)
  • Table 10 Global Medical Robotics Market Outlook, By General Surgery Robots (2023-2034) ($MN)
  • Table 11 Global Medical Robotics Market Outlook, By Rehabilitation Robots (2023-2034) ($MN)
  • Table 12 Global Medical Robotics Market Outlook, By Hospital & Pharmacy Robots (2023-2034) ($MN)
  • Table 13 Global Medical Robotics Market Outlook, By Automated Dispensing Robots (2023-2034) ($MN)
  • Table 14 Global Medical Robotics Market Outlook, By Disinfection & Sanitization Robots (2023-2034) ($MN)
  • Table 15 Global Medical Robotics Market Outlook, By Delivery & Transportation Robots (2023-2034) ($MN)
  • Table 16 Global Medical Robotics Market Outlook, By Telepresence Robots (2023-2034) ($MN)
  • Table 17 Global Medical Robotics Market Outlook, By Diagnostic Robots (2023-2034) ($MN)
  • Table 18 Global Medical Robotics Market Outlook, By Radiotherapy Robots (2023-2034) ($MN)
  • Table 19 Global Medical Robotics Market Outlook, By Component (2023-2034) ($MN)
  • Table 20 Global Medical Robotics Market Outlook, By Robotic Systems (2023-2034) ($MN)
  • Table 21 Global Medical Robotics Market Outlook, By Instruments & Accessories (2023-2034) ($MN)
  • Table 22 Global Medical Robotics Market Outlook, By Software (2023-2034) ($MN)
  • Table 23 Global Medical Robotics Market Outlook, By Services (2023-2034) ($MN)
  • Table 24 Global Medical Robotics Market Outlook, By Technology (2023-2034) ($MN)
  • Table 25 Global Medical Robotics Market Outlook, By Artificial Intelligence (AI) (2023-2034) ($MN)
  • Table 26 Global Medical Robotics Market Outlook, By Machine Learning (2023-2034) ($MN)
  • Table 27 Global Medical Robotics Market Outlook, By Computer Vision (2023-2034) ($MN)
  • Table 28 Global Medical Robotics Market Outlook, By Haptic Technology (2023-2034) ($MN)
  • Table 29 Global Medical Robotics Market Outlook, By Internet of Medical Things (IoMT) (2023-2034) ($MN)
  • Table 30 Global Medical Robotics Market Outlook, By Cloud Robotics (2023-2034) ($MN)
  • Table 31 Global Medical Robotics Market Outlook, By Control Mechanism (2023-2034) ($MN)
  • Table 32 Global Medical Robotics Market Outlook, By Direct Telemanipulator Systems (2023-2034) ($MN)
  • Table 33 Global Medical Robotics Market Outlook, By Computer-Controlled Systems (2023-2034) ($MN)
  • Table 34 Global Medical Robotics Market Outlook, By Shared-Control Systems (2023-2034) ($MN)
  • Table 35 Global Medical Robotics Market Outlook, By Application (2023-2034) ($MN)
  • Table 36 Global Medical Robotics Market Outlook, By Surgery (2023-2034) ($MN)
  • Table 37 Global Medical Robotics Market Outlook, By Rehabilitation Therapy (2023-2034) ($MN)
  • Table 38 Global Medical Robotics Market Outlook, By Diagnostics (2023-2034) ($MN)
  • Table 39 Global Medical Robotics Market Outlook, By Pharmacy Automation (2023-2034) ($MN)
  • Table 40 Global Medical Robotics Market Outlook, By Hospital Logistics (2023-2034) ($MN)
  • Table 41 Global Medical Robotics Market Outlook, By Telemedicine (2023-2034) ($MN)
  • Table 42 Global Medical Robotics Market Outlook, By Elderly Care (2023-2034) ($MN)
  • Table 43 Global Medical Robotics Market Outlook, By Radiation Therapy (2023-2034) ($MN)
  • Table 44 Global Medical Robotics Market Outlook, By End User (2023-2034) ($MN)
  • Table 45 Global Medical Robotics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 46 Global Medical Robotics Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 47 Global Medical Robotics Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 48 Global Medical Robotics Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
  • Table 49 Global Medical Robotics Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 50 Global Medical Robotics Market Outlook, By Pharmacies (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.